Jason Ryan
Chairman chez GENEDX HOLDINGS CORP.
Fortune : 2 M $ au 31/03/2024
Profil
Mr. Jason Ryan is a Chairman at GeneDx Holdings Corp.
and an Independent Director at Singular Genomics Systems, Inc. He is on the Board of Directors at Sema4, Inc. and Singular Genomics Systems, Inc. Mr. Ryan was previously employed as a Chairman by SomaLogic, Inc., an Independent Director by ArcherDX, Inc., a Chief Operating & Financial Officer by Magenta Therapeutics, Inc., a Chief Financial Officer by Foundation Medicine, Inc., a Senior Director-Finance & Business Operations by Taligen Therapeutics, Inc., a Director-Finance & Administration by Codon Devices, Inc., a Head-Finance & Administration by Genomics Collaborative, Inc., and an Audit Associate by Deloitte & Touche LLP.
He received his undergraduate degree from Bates College and an MBA from Babson College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/01/2024 | 188 356 ( 0,72% ) | 2 M $ | 31/03/2024 | |
| 29/02/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Jason Ryan
| Sociétés | Poste | Début |
|---|---|---|
| SINGULAR GENOMICS SYSTEMS, INC. | Director/Board Member | 01/04/2021 |
| GENEDX HOLDINGS CORP. | Chairman | 18/01/2022 |
Sema4, Inc.
 Sema4, Inc. Investment ManagersFinance Sema4, Inc. provides general underwriting services. The company is headquartered in Unionville, CT. | Director/Board Member | 01/07/2021 |
Anciens postes connus de Jason Ryan
| Sociétés | Poste | Fin |
|---|---|---|
| STANDARD BIOTOOLS INC. | Chairman | 05/01/2024 |
ArcherDX LLC
 ArcherDX LLC Packaged SoftwareTechnology Services ArcherDX LLC is a genomic analysis company, which develops software solutions for investigating cancer treatment. Its products include VariantPlex, FusionPlex, LiquidPlex, reveal ctDNA, Immunoverse, custom assays, and archer analysis. The company was founded by Jason W. Myers, A. John Iafrate, and Long Phi Le on January 1, 2013 and is headquartered in Boulder, CO. | Director/Board Member | 01/10/2020 |
| MAGENTA THERAPEUTICS | Director of Finance/CFO | 01/10/2020 |
| FOUNDATION MEDICINE INC | Director of Finance/CFO | 01/11/2018 |
Taligen Therapeutics, Inc.
 Taligen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Taligen Therapeutics is a biotechnology company pioneering a new approach to treating inflammatory and immune diseases by regulating the complement system, a potent and ubiquitous immune pathway. Based on new insights and unique proprietary technology related to complement biology, Taligen is building a deep product candidate pipeline of novel protein therapeutics which selectively identify, target and concentrate on inflammatory tissues. Taligen's targeted drugs have been shown to naturally and broadly control aberrant inflammation in a broad array of genetic, orphan and large market diseases. Founded in 2004, Taligen Therapeutics maintains its headquarters in Cambridge, Massachusetts. | Director of Finance/CFO | - |
Formation de Jason Ryan
| Babson College | Masters Business Admin |
| Bates College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SINGULAR GENOMICS SYSTEMS, INC. | Health Technology |
| GENEDX HOLDINGS CORP. | Health Services |
| STANDARD BIOTOOLS INC. | Commercial Services |
| Entreprise privées | 8 |
|---|---|
Taligen Therapeutics, Inc.
Taligen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Taligen Therapeutics is a biotechnology company pioneering a new approach to treating inflammatory and immune diseases by regulating the complement system, a potent and ubiquitous immune pathway. Based on new insights and unique proprietary technology related to complement biology, Taligen is building a deep product candidate pipeline of novel protein therapeutics which selectively identify, target and concentrate on inflammatory tissues. Taligen's targeted drugs have been shown to naturally and broadly control aberrant inflammation in a broad array of genetic, orphan and large market diseases. Founded in 2004, Taligen Therapeutics maintains its headquarters in Cambridge, Massachusetts. | Health Technology |
Codon Devices, Inc.
 Codon Devices, Inc. Pharmaceuticals: MajorHealth Technology Codon Devices, Inc. produces pharmaceuticals and biorefineries for the production of industrial chemicals and bio-energy. The firm designs and constructs biological components such as enzymes, biopharmaceuticals, and cell lines for improved function. Its customers include the biotechnology, pharmaceutical, and agriculture sectors. The company was founded by Noubar B. Afeyan, George Church, Drew Endy, Joseph M. Jacobson and Jay Keasling in 2004 and is headquartered in Cambridge, MA. | Health Technology |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
Genomics Collaborative, Inc.
 Genomics Collaborative, Inc. Medical SpecialtiesHealth Technology Genomics Collaborative, Inc. provides clinical samples and applies human genetics to target validation for drug discovery. The company is based in Cambridge, MA. The company was founded by Phyllis I. Gardner and Edward E. Harlow. Genomics Collaborative was acquired by BioServe Biotechnologies Ltd., a SUB of ReproCELL, Inc. from SeraCare Life Sciences, Inc. on May 29, 2007 for $2 million. | Health Technology |
Foundation Medicine, Inc.
 Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Foundation Medicine, Inc. is a molecular information company, which engages in the provision of information on clinical treatment decisions for patients with cancer. The company was founded on January 10, 2010 and is headquartered in Cambridge, MA. | Health Services |
ArcherDX LLC
ArcherDX LLC Packaged SoftwareTechnology Services ArcherDX LLC is a genomic analysis company, which develops software solutions for investigating cancer treatment. Its products include VariantPlex, FusionPlex, LiquidPlex, reveal ctDNA, Immunoverse, custom assays, and archer analysis. The company was founded by Jason W. Myers, A. John Iafrate, and Long Phi Le on January 1, 2013 and is headquartered in Boulder, CO. | Technology Services |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Sema4, Inc.
Sema4, Inc. Investment ManagersFinance Sema4, Inc. provides general underwriting services. The company is headquartered in Unionville, CT. | Finance |
